Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-31
DOI
10.1038/s41467-022-32310-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative
- (2020) Lucinda S. Orsini et al. VALUE IN HEALTH
- When to replicate systematic reviews of interventions: consensus checklist
- (2020) Peter Tugwell et al. BMJ-British Medical Journal
- Glucose‐lowering medications and the risk of cancer: A methodological review of studies based on real‐world data
- (2019) Katsiaryna Bykov et al. DIABETES OBESITY & METABOLISM
- Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
- (2019) Elisabetta Patorno et al. DIABETES CARE
- Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
- (2018) Xavier Kurz et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
- (2018) Daniel C. Malone et al. VALUE IN HEALTH
- Real world evidence: experience and lessons from China
- (2018) Xin Sun et al. BMJ-British Medical Journal
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Real world evidence: experience and lessons from China
- (2018) Xin Sun et al. BMJ-British Medical Journal
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
- (2018) Sinéad M Langan et al. BMJ-British Medical Journal
- Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
- (2017) Shirley V. Wang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
- (2017) Amr Makady et al. VALUE IN HEALTH
- Benzodiazepines and risk of all cause mortality in adults: cohort study
- (2017) Elisabetta Patorno et al. BMJ-British Medical Journal
- Benzodiazepines and risk of all cause mortality in adults: cohort study
- (2017) Elisabetta Patorno et al. BMJ-British Medical Journal
- Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
- (2017) Seoyoung C. Kim et al. Arthritis & Rheumatology
- Building trust in real-world evidence and comparative effectiveness research: the need for transparency
- (2017) Richard White Journal of Comparative Effectiveness Research
- Comparative Effectiveness of Rapid-Acting Insulins in Adults with Diabetes
- (2017) Patrick N. Racsa et al. Journal of Managed Care & Specialty Pharmacy
- The FDA's sentinel initiative-A comprehensive approach to medical product surveillance
- (2016) R Ball et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
- (2016) SV Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real-world” observational study in the United States
- (2016) Gregory Y. H. Lip et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer
- (2016) Jinhai Huo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Evaluating replicability of laboratory experiments in economics
- (2016) C. F. Camerer et al. SCIENCE
- Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
- (2016) Lars G Hemkens et al. BMJ-British Medical Journal
- Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
- (2016) Lars G Hemkens et al. BMJ-British Medical Journal
- From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients
- (2015) H-G Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
- (2015) Elisabetta Patorno et al. DRUG SAFETY
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The cancer test
- (2015) J. Kaiser SCIENCE
- Estimating the reproducibility of psychological science
- (2015) SCIENCE
- Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
- (2014) Elisabetta Patorno et al. DIABETOLOGIA
- Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
- (2014) Hana Müllerová et al. PLoS One
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Studies Analyzed Like Randomized Experiments
- (2008) Miguel A. Hernán et al. EPIDEMIOLOGY
- Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death
- (2008) Sebastian Schneeweiss et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started